http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-107335049-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-28 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-28 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-12 |
| filingDate | 2017-08-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2019-10-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2019-10-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-107335049-B |
| titleOfInvention | Application of the composite family type cyclic peptide compounds as cGAS-STING signal pathway inhibitor |
| abstract | The application of application and composite family type cyclic peptide compounds or its salt pharmacologically allowed as cGAS-STING signal pathway inhibitor in the drug of the disease of preparation treatment cGAS-STING signal path abnormal activation that the invention discloses a kind of composite family type cyclic peptide compounds or its salt pharmacologically allowed as cGAS-STING signal pathway inhibitor.Since composite family type cyclic peptide compounds of the present invention are native compound, dosage form and application method diversification, there is extensive potential applicability in clinical practice. |
| priorityDate | 2017-08-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 54.